Drug Profile
MTC-Oxaliplatin
Alternative Names: MTC-OXPTLatest Information Update: 13 Jan 2022
Price :
$50
*
At a glance
- Originator FeRx
- Class Antineoplastics; Platinum complexes; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 13 Jul 2004 Preclinical trials in Colorectal cancer in USA (unspecified route)